Cargando…
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)
OBJECTIVES: To describe clinical characteristics and outcomes of COVID-19 patients who developed secondary infections due to carbapenem-resistant Enterobacterales (CRE). METHODS: Retrospective observational study including COVID-19 patients admitted to 12 Italian hospitals from March to December 202...
Autores principales: | Falcone, Marco, Suardi, Lorenzo Roberto, Tiseo, Giusy, Galfo, Valentina, Occhineri, Sara, Verdenelli, Stefano, Ceccarelli, Giancarlo, Poli, Melita, Merli, Marco, Bavaro, Davide, Carretta, Anna, Nunnari, Giuseppe, Venanzi Rullo, Emmanuele, Trecarichi, Enrico Maria, Papalini, Chiara, Franco, Antonina, Del Vecchio, Rosa Fontana, Bianco, Vincenzo, Punzi, Rodolfo, Francisci, Daniela, Rubino, Raffaella, Torti, Carlo, Puoti, Massimo, Carbonara, Sergio, Cascio, Antonio, Saracino, Annalisa, Santantonio, Teresa, Venditti, Mario, Menichetti, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201238/ https://www.ncbi.nlm.nih.gov/pubmed/35719203 http://dx.doi.org/10.1093/jacamr/dlac064 |
Ejemplares similares
-
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID‐19 admitted to hospital: An observational prospective study
por: Tiseo, Giusy, et al.
Publicado: (2022) -
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
por: Tiseo, Giusy, et al.
Publicado: (2022) -
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern
por: Falcone, Marco, et al.
Publicado: (2021) -
What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?
por: Tiseo, Giusy, et al.
Publicado: (2023) -
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19
por: Falcone, Marco, et al.
Publicado: (2022)